89bio (ETNB) Short Interest Ratio & Short Volume $7.98 -0.01 (-0.13%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends 89bio Short Interest Data89bio (ETNB) has a short interest of 5.38 million shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 9.3, indicating that it would take 9.3 days of the average trading volume of 1.01 million shares to cover all short positions.Current Short Interest5,380,000 sharesPrevious Short Interest5,380,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$41.86 millionShort Interest Ratio9.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares106,130,000 sharesPercentage of Shares Shorted5.07%Today's Trading Volume674,060 sharesAverage Trading Volume1,007,813 sharesToday's Volume Vs. Average67% Short Selling 89bio? Sign up to receive the latest short interest report for 89bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartETNB Short Interest Over TimeETNB Days to Cover Over TimeETNB Percentage of Float Shorted Over Time Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 89bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20245,380,000 shares $41.86 million No ChangeN/A9.3 $7.78 10/15/20245,380,000 shares $43.15 million -16.6%N/A9.7 $8.02 9/30/20246,450,000 shares $47.73 million -7.1%N/A10.5 $7.40 9/15/20246,940,000 shares $58.85 million +1.5%N/A9.5 $8.48 8/31/20246,840,000 shares $64.98 million No ChangeN/A8.1 $9.50 8/15/20246,840,000 shares $55.88 million +5.2%N/A7.2 $8.17 Get the Latest News and Ratings for ETNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 89bio and its competitors with MarketBeat's FREE daily newsletter. 7/31/20246,500,000 shares $59.54 million +5.5%N/A6.6 $9.16 7/15/20246,160,000 shares $55.44 million -4.1%N/A6.2 $9.00 6/30/20246,420,000 shares $51.42 million -28.8%N/A6.7 $8.01 6/15/20249,020,000 shares $79.11 million -14.7%N/A10 $8.77 5/31/202410,580,000 shares $83.58 million +4.6%N/A11.4 $7.90 5/15/202410,120,000 shares $93.10 million -5.9%N/A9.6 $9.20 4/30/202410,750,000 shares $91.48 million -4.1%N/A9.4 $8.51 4/15/202411,210,000 shares $106.38 million -2.9%N/A8.9 $9.49 3/31/202411,550,000 shares $134.44 million +4.0%N/A8.8 $11.64 3/15/202411,110,000 shares $150.21 million +2.3%N/A8.2 $13.52 2/29/202410,860,000 shares $124.56 million +2.7%N/A7.6 $11.47 2/15/202410,580,000 shares $103.58 million +9.9%N/A7.8 $9.79 1/31/20249,630,000 shares $95.34 million +7.2%N/A7.1 $9.90 1/15/20248,980,000 shares $99.59 million +5.9%N/A6.7 $11.09 12/31/20238,480,000 shares $94.72 million +24.5%N/A4.9 $11.17 12/15/20236,810,000 shares $72.19 million +12.0%N/A3.9 $10.60 11/30/20236,080,000 shares $48.88 million +0.7%N/A3.6 $8.04 11/15/20236,040,000 shares $45.96 million +11.2%N/A3.9 $7.61 10/31/20235,430,000 shares $40.18 million -19.1%N/A3.7 $7.40 10/15/20236,710,000 shares $51.13 million +6.0%N/A4.7 $7.62 9/30/20236,330,000 shares $97.74 million +7.5%N/A5.6 $15.44 9/15/20235,890,000 shares $102.25 million -6.4%N/A5.7 $17.36 8/31/20236,290,000 shares $107.81 million -28.4%N/A5.3 $17.14 8/15/20238,780,000 shares $147.07 million +9.5%N/A6.9 $16.75 7/31/20238,020,000 shares $127.04 million -11.2%N/A6 $15.84 7/15/20239,030,000 shares $164.80 million -5.0%N/A6.7 $18.25 6/30/20239,500,000 shares $180.03 million +36.5%N/A6.6 $18.95 6/15/20236,960,000 shares $144.00 million -2.3%N/A4 $20.69 5/31/20237,120,000 shares $129.80 million -1.4%N/A3.2 $18.23 5/15/20237,220,000 shares $129.02 million -4.4%N/A3.3 $17.87 4/30/20237,550,000 shares $120.65 million -1.2%N/A3.4 $15.98 4/15/20237,640,000 shares $118.57 million -5.1%N/A3.5 $15.52 3/31/20238,050,000 shares $122.60 million +44.0%N/A3.9 $15.23 3/15/20235,590,000 shares $71.50 million +8.5%N/A2.9 $12.79This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 2/28/20235,150,000 shares $70.14 million +10.8%N/A4.8 $13.62 2/15/20234,650,000 shares $60.45 million No ChangeN/A4.5 $13.00 1/31/20234,650,000 shares $54.31 million +8.6%N/A4.8 $11.68 1/15/20234,280,000 shares $44.94 million -3.4%N/A4.8 $10.50 12/30/20224,430,000 shares $56.39 million -7.1%N/A4.9 $12.73 12/15/20224,770,000 shares $49.37 million +30.3%N/A5.3 $10.35 11/30/20223,660,000 shares $29.28 million No ChangeN/A2.7 $8.00 11/15/20223,660,000 shares $35.83 million -0.3%N/A2.8 $9.79 10/31/20223,670,000 shares $35.05 million -3.2%N/A2.8 $9.55 10/15/20223,790,000 shares $29.07 million +28.0%N/A3 $7.67 9/30/20222,960,000 shares $17.14 million -6.0%N/A2.6 $5.79 9/15/20223,150,000 shares $18.43 million +55.2%N/A2.7 $5.85 8/31/20222,030,000 shares $9.05 million +1.0%N/A4.2 $4.46 8/15/20222,010,000 shares $9.53 million +34.9%N/A4.1 $4.74 7/31/20221,490,000 shares $5.29 million -2.6%N/A3.3 $3.55 7/15/20221,530,000 shares $5.31 million +75.0%N/A3.7 $3.47 6/30/2022874,500 shares $2.82 million -15.9%N/A2.2 $3.22 6/15/20221,040,000 shares $3.28 million -7.1%7.3%3.8 $3.15 5/31/20221,120,000 shares $3.37 million +16.1%7.8%4.6 $3.01 5/15/2022964,800 shares $2.55 million +20.1%6.8%5 $2.64 4/30/2022803,200 shares $1.74 million +17.1%5.6%4.1 $2.17 4/15/2022686,200 shares $2.02 million +5.5%4.8%3.4 $2.95 3/31/2022650,300 shares $2.45 million -9.5%4.6%3.6 $3.77 3/15/2022718,900 shares $2.57 million +10.9%5.1%4.1 $3.58 2/28/2022648,300 shares $3.00 million -6.4%4.6%3.8 $4.63 2/15/2022692,700 shares $3.50 million -1.8%4.9%4.1 $5.05 1/31/2022705,500 shares $4.16 million +14.7%5.2%5 $5.89 1/15/2022615,100 shares $7.46 million +5.4%4.5%7.5 $12.12 12/31/2021583,500 shares $7.63 million +93.3%4.3%7.5 $13.07 12/15/2021301,800 shares $3.68 million -37.2%2.2%3.9 $12.19 11/30/2021480,800 shares $6.35 million +1.0%3.5%6.3 $13.21 11/15/2021475,900 shares $8.11 million -40.1%3.5%6.4 $17.05 10/29/2021793,900 shares $13.97 million -5.8%5.9%10.1 $17.60 10/15/2021843,000 shares $15.23 million -10.0%6.3%10 $18.07 9/30/2021936,100 shares $18.34 million -0.3%7.0%10.7 $19.59 9/15/2021938,900 shares $18.84 million -5.7%7.0%9.5 $20.07 8/31/2021995,600 shares $18.43 million -8.7%7.5%10.1 $18.51 8/13/20211,090,000 shares $20.12 million -9.2%8.2%9.7 $18.46 7/30/20211,200,000 shares $18.79 million +2.6%9.0%11 $15.66 7/15/20211,170,000 shares $19.54 million +13.6%6.9%11.5 $16.70 6/30/20211,030,000 shares $19.26 million -27.5%6.0%9.7 $18.70 6/15/20211,420,000 shares $28.05 million -0.7%8.3%14.9 $19.75 5/28/20211,430,000 shares $27.03 million +8.3%8.4%14.8 $18.90 5/14/20211,320,000 shares $26.89 million -1.5%7.7%13.7 $20.37 4/30/20211,340,000 shares $36.15 million -0.7%7.9%14 $26.98 4/15/20211,350,000 shares $32.10 million +20.5%N/A0 $23.78 3/31/20211,120,000 shares $26.57 million No Change6.6%7.6 $23.72 3/15/20211,120,000 shares $28.07 million -3.5%6.6%6.4 $25.06 2/26/20211,160,000 shares $28.85 million -0.9%6.9%6.4 $24.87 2/12/20211,170,000 shares $28.03 million No Change6.9%6.5 $23.96This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 1/29/20211,170,000 shares $23.66 million +17.4%7.0%6.1 $20.22 1/15/2021996,900 shares $21.49 million +41.2%6.0%5.2 $21.56 12/31/2020705,900 shares $18.06 million +30.9%4.2%3.8 $25.58 12/15/2020539,100 shares $14.26 million -4.0%3.2%3.2 $26.45 11/30/2020561,800 shares $15.33 million +82.3%3.4%2.8 $27.28 11/15/2020308,100 shares $8.28 million +14.3%1.8%1.5 $26.88 10/30/2020269,600 shares $6.50 million +41.8%1.7%1.5 $24.12 10/15/2020190,200 shares $4.55 million -61.9%1.2%1.2 $23.90 9/30/2020498,500 shares $12.79 million +175.9%3.1%3.4 $25.66 9/15/2020180,700 shares $5.50 million +29.8%1.2%1.1 $30.44 8/31/2020139,200 shares $5.36 million +14.7%1.1%1.4 $38.50 8/14/2020121,400 shares $3.66 million -59.5%0.9%1.2 $30.15 7/31/2020299,900 shares $9.11 million +120.5%2.5%3.2 $30.38 7/15/2020136,000 shares $4.23 million -82.4%1.1%1.5 $31.12 6/30/2020774,200 shares $15.43 million +36.6%7.7%9 $19.93 6/15/2020566,900 shares $14.67 million +1.4%5.6%13.1 $25.87 5/29/2020558,900 shares $14.40 million -5.1%5.5%11.2 $25.76 5/15/2020588,900 shares $14.68 million -11.3%5.8%11.5 $24.93 4/30/2020664,100 shares $17.25 million +2.7%6.6%13.5 $25.98 4/15/2020646,400 shares $14.61 million +23.1%6.4%13.1 $22.60 3/31/2020525,000 shares $13.68 million +9.6%5.2%9.7 $26.05 3/13/2020479,100 shares $9.95 million +22.3%4.8%10.3 $20.76 2/28/2020391,800 shares $10.16 million -0.4%3.9%6 $25.93 2/14/2020393,400 shares $13.61 million -6.1%3.9%5.6 $34.60 1/31/2020418,900 shares $14.33 million -9.4%4.6%4.9 $34.22 1/15/2020462,500 shares $13.23 million +16.0%5.1%4.9 $28.60 12/31/2019398,600 shares $10.42 million No Change4.5%3.9 $26.15 ETNB Short Interest - Frequently Asked Questions What is 89bio's current short interest? Short interest is the volume of 89bio shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 5,380,000 shares of ETNB short. Learn More on 89bio's current short interest. What is a good short interest ratio for 89bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ETNB shares currently have a short interest ratio of 9.0. Learn More on 89bio's short interest ratio. Which institutional investors are shorting 89bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of 89bio: Crawford Fund Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. How does 89bio's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to 89bio: MoonLake Immunotherapeutics (15.30%), Agios Pharmaceuticals, Inc. (7.85%), Verona Pharma plc (9.41%), PTC Therapeutics, Inc. (6.34%), Dyne Therapeutics, Inc. (9.77%), Bausch Health Companies Inc. (3.59%), Edgewise Therapeutics, Inc. (12.19%), Merus (12.65%), Xenon Pharmaceuticals Inc. (3.79%), HUTCHMED (China) Limited (0.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short 89bio stock? Short selling ETNB is an investing strategy that aims to generate trading profit from 89bio as its price is falling. ETNB shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 89bio? A short squeeze for 89bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ETNB, which in turn drives the price of the stock up even further. How often is 89bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ETNB, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies MoonLake Immunotherapeutics Short Interest Agios Pharmaceuticals Short Interest Verona Pharma Short Interest PTC Therapeutics Short Interest Dyne Therapeutics Short Interest Bausch Health Companies Short Interest Edgewise Therapeutics Short Interest Merus Short Interest Xenon Pharmaceuticals Short Interest HUTCHMED Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ETNB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 89bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
